Galena Biopharma fka GALE

[Euripides90]

Challenges are opportunities comes to mind, sure hope so: this company owes Longs big-time for the miscalculations over Neuvax.
Among other things.

Longs have the dubious distinction of holding one of the 30 worst- performing stocks so far this year and one of 3 in that category trading below a buck on the Big Boards.

In 2015 (and 2014 and 2013 for that matter), biotech stocks littered the list of best performers. This year, the chicken has come home to roost for many stocks in the biotech group. Of the 30 worst-performing Russell 3,000 stocks year to date shown below, 20 are biotech-related.

http://seekingalpha.com/article/4001710-best-worst-performing-stocks-2016

There is much potential here but let's hope we see MOMO soon;
institutions are reportedly buying this up, cheapest big biotech.